Breast reduction does not require implants
Welsh J, Amini A, Likhacheva A, Erasmus J J, Gomez D, Davila M, Mehran RJ, Komaki R, Liao Z, Hofstetter WL , Lee H J, Bhutani MS, Ajani JA
Key Points Tirzepatide works on two hormone pathways (GLP-1 and GIP) while semaglutide targets one pathway (GLP-1) that reduces appetite and controls blood sugar levels In a direct comparison, tirzepatide helped people lose more weight, on average Both medications require weekly injections and have similar side effects, like nausea and digestive issues Additionally, semaglutide has FDA approval for heart protection benefits, while tirzepatide is approved for sleep apnea treatment Both tirzepatide (Mounjaro, Zepbound) and semaglutide (Ozempic, Wegovy) are transforming how doctors treat type 2 diabetes and obesity, but they're not identical medications
Treatment Support May be used within a broader clinician-guided approach to weight management and related health goals